<SEC-DOCUMENT>0001493152-19-004924-index.html : 20190405 <SEC-HEADER>0001493152-19-004924.hdr.sgml : 20190405 <ACCEPTANCE-DATETIME>20190405092915 ACCESSION NUMBER: 0001493152-19-004924 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20190404 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190405 DATE AS OF CHANGE: 20190405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adhera Therapeutics, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 19733616 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-578-5901 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Marina Biotech, Inc. DATE OF NAME CHANGE: 20100722 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8-k.htm <TEXT> Document 1 - file: form8-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>ex10-1.htm <TEXT> Document 2 - file: ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>3 <FILENAME>ex10-2.htm <TEXT> Document 3 - file: ex10-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>ex99-1.htm <TEXT> Document 4 - file: ex99-1.htm
</DOCUMENT> </SEC-DOCUMENT>